Danish pharma agrees cap on medicine prices for the coming three years

A three year price-cap agreement on medicine prices has been signed by Denmark’s Minister of Health and Prevention, Astrid Krag, and the chairperson of the Danish Association of the Pharmaceutical Industry (Lif), Dorthe Mikkelsen.

The agreement is a continuation of the existing agreement from 2008, and means that the price of reimbursable prescription medicines sold at the Danish pharmacies over the next 15 months cannot be raised over the cap that applies in the present price-cap agreement. The parties have agreed that the present cap should continue until April 1, 2013 when the cap can be adjusted for the first time by 1.5%. The cap will be adjusted by a further 1.5% on April 1, 2014. The adjustment has been agreed to take some account of the consequences of general cost trends.

Result of lengthy negotiations